2010
Association between family history of cancers and risk of prostate cancer
Sridhar G, Masho S, Adera T, Ramakrishnan V, Roberts J. Association between family history of cancers and risk of prostate cancer. Journal Of Men's Health 2010, 7: 45-54. DOI: 10.1016/j.jomh.2009.10.006.Peer-Reviewed Original ResearchFirst-degree relativesBody mass indexProstate cancer riskProstate cancerFamily historyOdds ratioCancer riskMethodsA case–control studyUnconditional logistic regression analysisHistory of vasectomyConfidence intervalsProstate cancer patientsCase-control studyPotential confounding factorsLogistic regression analysisHealth care providersMass indexAlcohol intakeUrology clinicCancer patientsRisk factorsUrological illnessesPhysical activityCare providersConclusionThis study
2005
Use of an implantable drug delivery system for refractory chronic sickle cell pain
Smith TJ, Coyne PJ, Smith WR, Roberts JD, Smith V. Use of an implantable drug delivery system for refractory chronic sickle cell pain. American Journal Of Hematology 2005, 78: 153-154. PMID: 15682408, DOI: 10.1002/ajh.20252.Peer-Reviewed Original ResearchConceptsImplantable intrathecal drug delivery systemsSickle cell patientsCell patientsChronic sickle cell painIntrathecal drug delivery systemsRefractory bone painRefractory cancer painSustained-release opioidsSickle cell painRandomized clinical trialsComprehensive medical managementBone painCancer painRefractory painProspective trialSustained reliefMedical managementCancer patientsDrug delivery systemsClinical trialsPainClinical successPatientsDelivery systemImplantable drug delivery systems
1991
Effect of obesity on plasma insulin-like growth factor-I in cancer patients.
Colletti RB, Copeland KC, Devlin JT, Roberts JD, McAuliffe TL. Effect of obesity on plasma insulin-like growth factor-I in cancer patients. International Journal Of Obesity 1991, 15: 523-7. PMID: 1938095.Peer-Reviewed Original ResearchConceptsMidarm muscle areaTriceps skinfold thicknessIndices of adiposityCancer patientsPlasma IGFNutritional statusPlasma insulin-like growth factor IScreening testPlasma insulin-like growth factorPlasma IGF-I concentrationsInsulin-like growth factor IInsulin-like growth factorUtility of IGFPercent of patientsEffect of obesityBody mass indexIGF-I concentrationsUseful screening testGrowth factor IGender-specific fashionLog IGFMass indexAnthropometric measurementsSkinfold thicknessBody weight
1989
Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer.
Colletti RB, Roberts JD, Devlin JT, Copeland KC. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Research 1989, 49: 1882-4. PMID: 2924327.Peer-Reviewed Original ResearchConceptsInsulin-like growth factor IBreast cancer patientsGrowth factor ICancer patientsPlasma IGFBreast cancerAmbulatory breast cancer patientsPlasma insulin-like growth factor IFactor IPlasma IGF-I concentrationsPlasma IGF-I levelsAntiestrogen agent tamoxifenRecent weight lossIGF-I levelsEffect of tamoxifenIGF-I concentrationsHuman breast cancer cellsSuppression of IGFGrowth hormone-dependent peptideBreast cancer cellsMetastatic diseasePlasma concentrationsPatientsTamoxifenNutritional status